US 12,263,248 B2
Compounds and compositions for intracellular delivery of therapeutic agents
Kerry E. Benenato, Sudbury, MA (US); Mark Cornebise, Arlington, MA (US); and Edward Hennessy, Westwood, MA (US)
Assigned to ModernaTX, Inc., Cambridge, MA (US)
Appl. No. 17/278,040
Filed by ModernaTX, Inc., Cambridge, MA (US)
PCT Filed Sep. 19, 2019, PCT No. PCT/US2019/052009
§ 371(c)(1), (2) Date Mar. 19, 2021,
PCT Pub. No. WO2020/061367, PCT Pub. Date Mar. 26, 2020.
Claims priority of provisional application 62/798,874, filed on Jan. 30, 2019.
Claims priority of provisional application 62/733,315, filed on Sep. 19, 2018.
Prior Publication US 2022/0409536 A1, Dec. 29, 2022
Int. Cl. A61K 9/127 (2006.01); A61K 31/167 (2006.01); A61K 31/519 (2006.01); A61K 31/573 (2006.01); A61K 31/7105 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); C07C 215/08 (2006.01); C07C 229/12 (2006.01); C07C 229/14 (2006.01); C07C 229/16 (2006.01); C07C 233/47 (2006.01); C07C 235/10 (2006.01); C07C 275/14 (2006.01); C07C 279/28 (2006.01); C07C 279/36 (2006.01); C07C 311/05 (2006.01); C07C 311/14 (2006.01); C07C 311/64 (2006.01); C07C 335/08 (2006.01); C07D 209/48 (2006.01); C07D 233/61 (2006.01); C07D 239/47 (2006.01); C07D 239/54 (2006.01); C07D 249/04 (2006.01); C07D 295/13 (2006.01); C07D 473/18 (2006.01); C07D 473/34 (2006.01); C07F 9/09 (2006.01); A61K 48/00 (2006.01)
CPC A61K 9/1272 (2013.01) [A61K 31/167 (2013.01); A61K 31/519 (2013.01); A61K 31/573 (2013.01); A61K 31/7105 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); C07C 215/08 (2013.01); C07C 229/12 (2013.01); C07C 229/14 (2013.01); C07C 229/16 (2013.01); C07C 233/47 (2013.01); C07C 235/10 (2013.01); C07C 275/14 (2013.01); C07C 279/28 (2013.01); C07C 279/36 (2013.01); C07C 311/05 (2013.01); C07C 311/14 (2013.01); C07C 311/64 (2013.01); C07C 335/08 (2013.01); C07D 209/48 (2013.01); C07D 233/61 (2013.01); C07D 239/47 (2013.01); C07D 239/54 (2013.01); C07D 249/04 (2013.01); C07D 295/13 (2013.01); C07D 473/18 (2013.01); C07D 473/34 (2013.01); C07F 9/091 (2013.01); A61K 48/00 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); C07C 2601/14 (2017.05); C07C 2601/16 (2017.05)] 15 Claims
 
1. A compound, selected from the group consisting of:

OG Complex Work Unit Chemistry
and salts thereof.